These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 20473947

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Upregulation of HYAL1 expression in breast cancer promoted tumor cell proliferation, migration, invasion and angiogenesis.
    Tan JX, Wang XY, Su XL, Li HY, Shi Y, Wang L, Ren GS.
    PLoS One; 2011; 6(7):e22836. PubMed ID: 21829529
    [Abstract] [Full Text] [Related]

  • 3. Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors.
    Franzmann EJ, Schroeder GL, Goodwin WJ, Weed DT, Fisher P, Lokeshwar VB.
    Int J Cancer; 2003 Sep 01; 106(3):438-45. PubMed ID: 12845686
    [Abstract] [Full Text] [Related]

  • 4. Stromal and epithelial expression of tumor markers hyaluronic acid and HYAL1 hyaluronidase in prostate cancer.
    Lokeshwar VB, Rubinowicz D, Schroeder GL, Forgacs E, Minna JD, Block NL, Nadji M, Lokeshwar BL.
    J Biol Chem; 2001 Apr 13; 276(15):11922-32. PubMed ID: 11278412
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Effect of silencing of hyaluronidase gene HYAL1 by RNA interference on proliferation of human breast cancer cells].
    Tan JX, Ren GS, Tu G, Li XT, Wang XY, Ran L.
    Ai Zheng; 2006 Jul 13; 25(7):844-8. PubMed ID: 16831275
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. PEA-15 inhibits tumorigenesis in an MDA-MB-468 triple-negative breast cancer xenograft model through increased cytoplasmic localization of activated extracellular signal-regulated kinase.
    Bartholomeusz C, Gonzalez-Angulo AM, Kazansky A, Krishnamurthy S, Liu P, Yuan LX, Yamasaki F, Liu S, Hayashi N, Zhang D, Esteva FJ, Hortobagyi GN, Ueno NT.
    Clin Cancer Res; 2010 Mar 15; 16(6):1802-11. PubMed ID: 20215547
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Capillary morphogenesis gene 2 inhibits growth of breast cancer cells and is inversely correlated with the disease progression and prognosis.
    Ye L, Sun PH, Malik MF, Mason MD, Jiang WG.
    J Cancer Res Clin Oncol; 2014 Jun 15; 140(6):957-67. PubMed ID: 24667935
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinicopathological significance of hyaluronan and hyaluronidase 2 (HYAL2) in breast cancer.
    Fujisawa S, Takagi K, Yamaguchi-Tanaka M, Sato A, Miki Y, Miyashita M, Tada H, Ishida T, Suzuki T.
    Pathol Res Pract; 2024 Aug 15; 260():155434. PubMed ID: 38991455
    [Abstract] [Full Text] [Related]

  • 17. Role of HYAL1 expression in primary breast cancer in the formation of brain metastases.
    Witzel I, Marx AK, Müller V, Wikman H, Matschke J, Schumacher U, Stürken C, Prehm P, Laakmann E, Schmalfeldt B, Milde-Langosch K, Oliveira-Ferrer L.
    Breast Cancer Res Treat; 2017 Apr 15; 162(3):427-438. PubMed ID: 28168629
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Evaluation of the prognostic potential of hyaluronic acid and hyaluronidase (HYAL1) for prostate cancer.
    Posey JT, Soloway MS, Ekici S, Sofer M, Civantos F, Duncan RC, Lokeshwar VB.
    Cancer Res; 2003 May 15; 63(10):2638-44. PubMed ID: 12750291
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.